Fukuhara, Hideo
Nohara, Takahiro
Nishimoto, Koshiro
Hatakeyama, Yutaka
Hyodo, Yuki
Okuhara, Yoshiyasu
Oyama, Masafumi
Mizokami, Atsushi
Inoue, Keiji
Matsuyama, Hideyasu
,
Article History
Received: 24 April 2021
Accepted: 8 November 2021
First Online: 13 November 2021
Declarations
:
: This retrospective study was approved by the Ethics committee of Kochi Medical School (approved no. 31–88), and the requirement to obtain informed consent was waived for the retrospective study. Ethical approval from the local committee and the IDs are the following:Kanazawa university Ethics committee, ID: 3172–1.Saitama Medical University International Medical Center Ethics committee, ID: 19–217.
: Not applicable.
: The authors report the following financial interests;KI; Chugai Pharmaceutical Co., Ltd. – speaker fees.HM; Chugai Pharmaceutical Co., Ltd. – speaker fees.All other authors have nothing to disclose. Chugai Pharmaceutical Co., Ltd. played no role in the study design, data collection and analysis, decision to submit for publication, or preparation of the manuscript.